Nira Medical and Rocky Mountain MS Clinic Unveil AI-Powered MS Registry
Nira Medical and the Rocky Mountain MS Clinic have announced the presentation of a pioneering AI-powered multiple sclerosis (MS) registry at the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress. Announced in a press release, this initiative aims to transform fragmented electronic health record (EHR) data into a comprehensive, scalable registry to advance MS research and care.
The project employs the Century Health Abstraction and Retrieval Model (CHARM), a large language model fine-tuned for MS-specific clinical data. This model has been applied to a cohort of over 4,200 patients from the Rocky Mountain MS Clinic, enabling the accurate abstraction of critical clinical variables from unstructured EHR data. Key findings include the successful abstraction of EDSS scores in over 97% of visits and insights into MS subtypes, treatment history, and imaging patterns.
This AI-driven method significantly reduces the time required for manual data work, allowing for the creation of larger, more representative MS registries. These registries can accelerate drug development, improve clinical trial design, and enhance patient care by providing high-fidelity insights into treatment outcomes and disease progression.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind AccessLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Linearis Joins Two Canadian AI Health Data Projects
CureMD Earns ISO/IEC 42001 Certification for AI Management
ARUP Selected for Redtail Clinical AI Project
wisepatientAI Launches AI Search for Medical Records
ARPA-H Funds $28.6 Million AI Protein Research Project
Daily AI Brief: the AI news that matters, in your inbox.